98%
921
2 minutes
20
Background: Per- and polyfluoroalkyl substances (PFAS) are a large class of synthetic chemicals with ubiquitous human exposure. Maternal PFAS exposure has been linked with adverse birth outcomes, but their associations with preterm birth (PTB) remained ambiguous.
Methods: To assess the associations of individual and mixed PFAS exposure with preterm birth (PTB) and its subtypes (spontaneous and iatrogenic), a nested case-control study involving 177 PTB cases and 531 controls was conducted in Shanghai, China. Serum concentration of seven PFAS were measured in early pregnancy via ultrahigh-performance liquid chromatography tandem mass spectrometry (UHPLC-MS/MS). PTB, gestational weeks and birth weight were obtained from electronic medical record system. Conditional logistic regression and restricted cubic spline regression (RCS) were used for individual assessment. Weighted quantile sum (WQS) regression, quantile-based g-computation (QGC), and Bayesian kernel machine regression (BKMR) were conducted for PFAS mixture. Subtype analysis and sex stratified analysis were further examined.
Results: Both individually and in mixtures, significant associations were observed between elevated PFAS concentrations and increased PTB risk, along with reduced gestational weeks and lower birth weight. The WQS, QGC, and BKMR identified perfluorooctanoic acid (PFOA), per-fluorononanoic acid (PFNA), and perfluoroundecanoic acid (PFUnDA) as the major contributors, with PFOA being particularly significant. Moreover, higher risks of PFAS-associated PTB were observed in the iatrogenic PTB subgroup and pregnant women with male infants.
Conclusion: Maternal exposure to PFAS, whether individually or in mixtures, was significantly associated with increased risk of PTB. These associations might be subtype-specific and sex-specific. Further research is needed to validate our results and elucidate the underlying mechanisms.
Supplementary Information: The online version contains supplementary material available at 10.1186/s12940-025-01213-3.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12363060 | PMC |
http://dx.doi.org/10.1186/s12940-025-01213-3 | DOI Listing |
Am J Respir Crit Care Med
September 2025
University of Padova, 1Department of Women's and Children's Health, University of Padova, Padova, Veneto, Italy.
Braz Oral Res
September 2025
Universidade Federal de Minas Gerais - UFMG, School of Dentistry, Department of Restorative Dentistry, Belo Horizonte, MG, Brazil.
This study aimed to determine the prevalence and provide an overview of Down syndrome and child- and mother-associated factors in Brazil from 2010 to 2020. This was a cross-sectional study including epidemiological characteristics related to live births of individuals with and without Down syndrome using the Brazilian government website. The average prevalence of Down syndrome in Brazil was approximately 30.
View Article and Find Full Text PDFPLoS One
September 2025
Department of Pathology, Boston Children's Hospital, Harvard School of Medicine, Boston, Massachusetts, United States of America.
The Sudden Infant Death Syndrome (SIDS) is a major global health problem, with increased risk among socioeconomically disadvantaged populations. We propose SIDS, or a subset, is due to a defect in the brainstem serotonin system mediating cardiorespiratory integration and arousal. This defect impinges on homeostasis during a critical developmental period in infancy, especially in populations experiencing maternal and infantile stress, resulting in sleep-related sudden death.
View Article and Find Full Text PDFBiomed Environ Sci
August 2025
Department of Environmental Health & Environment and Health Innovation Team, School of Public Health, Zhengzhou University, Zhengzhou 450001, Henan, China;National Health Commission Key Laboratory of Birth Defects Prevention, Zhengzhou 450002, Henan, China;Yellow River Institute for Ecological Prote
Acta Obstet Gynecol Scand
September 2025
Unit of Gynecological Oncology, Department of Oncology, KU Leuven, Leuven, Belgium.
Introduction: Vulvovaginal cancer in pregnancy is rare. Limited data complicate decision-making and patient counseling. Our review, coupled with new case data, fills a current gap in the literature and provides practical insights.
View Article and Find Full Text PDF